DXR
Daxor Corporation
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$10.27
−2.66%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-0.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 1, 2026 | Jefferies John · officer: Chief Medical Officer | A-Award | 2,451 | $0.00 |
| Jun 25, 2026 | Michel Robert J · officer: Chief Financial Officer | A-Award | 12,000 | $0.00 |
| Jun 25, 2026 | DesRosiers Caleb · director | A-Award | 2,500 | $10 |
| Jun 25, 2026 | Feuer Edward · director | A-Award | 2,500 | $10 |
| Jun 25, 2026 | Cremisi Henry D. · director | A-Award | 2,500 | $10 |
| Jun 25, 2026 | Goudie Joy S. · director | A-Award | 2,500 | $10 |
| Jun 25, 2026 | Feldschuh Jonathan Adam · director, officer: Chief Scientific Officer | A-Award | 25,000 | $0.00 |
| Jun 25, 2026 | Feldschuh Michael Richard · director, officer: Chief Executive Officer | A-Award | 30,000 | $0.00 |
| Apr 10, 2026 | Feldschuh Michael Richard · director, officer: Chief Executive Officer | Purchase | 1,000 | $9.07 |
| Mar 31, 2026 | Michel Robert J · officer: Chief Financial Officer | Purchase | 1,000 | $9.90 |
| Mar 24, 2026 | Jefferies John · officer: Chief Medical Officer | Purchase | 3,656 | $0.00 |
| Mar 24, 2026 | Jefferies John · officer: Chief Medical Officer | Purchase | 2,285 | $0.00 |
| Dec 11, 2025 | Michel Robert J · officer: Chief Financial Officer | Purchase | 3,000 | $0.00 |
| Dec 11, 2025 | Feldschuh Jonathan Adam · director, officer: Chief Scientific Officer | Purchase | 18,000 | $0.00 |
| Nov 14, 2025 | Jefferies John · officer: Chief Medical Officer | Purchase | 2,344 | $0.00 |
| Jun 26, 2025 | Cremisi Henry D. · director | A-Award | 2,500 | $9.29 |
| Jun 26, 2025 | Feuer Edward · director | A-Award | 2,500 | $9.29 |
| Jun 26, 2025 | Goudie Joy S. · director | A-Award | 2,500 | $9.29 |
| Jun 26, 2025 | DesRosiers Caleb · director | A-Award | 2,500 | $9.29 |
| Apr 7, 2025 | Feldschuh Michael Richard · director, officer: Chief Executive Officer | Purchase | 2,063 | $7.89 |
| Mar 27, 2025 | Feldschuh Michael Richard · director, officer: Chief Executive Office | Purchase | 1,000 | $8.13 |
| Mar 20, 2025 | Feldschuh Michael Richard · director, officer: Chief Executive Officer | Purchase | 647 | $8.15 |
| Mar 20, 2025 | Feldschuh Michael Richard · director, officer: Chief Executive Officer | Purchase | 1,492 | $7.72 |
| Mar 11, 2025 | Michel Robert J · officer: Chief Financial Officer | Purchase | 1,000 | $8.00 |
| Mar 11, 2025 | Feldschuh Michael Richard · director, officer: Chief Executive Officer | Purchase | 3,360 | $7.68 |
| Dec 10, 2024 | Michel Robert J · officer: Chief Financial Officer | Purchase | 4,750 | $0.00 |
| Dec 10, 2024 | Feldschuh Michael Richard · director, officer: Chief Executive Officer | Purchase | 45,000 | $0.00 |
| Dec 10, 2024 | Feldschuh Jonathan Adam · director, officer: Chief Scientific Officer | Purchase | 32,000 | $0.00 |
| Jul 17, 2024 | Cremisi Henry D. · director | A-Award | 2,500 | $9.20 |
| Jul 17, 2024 | DesRosiers Caleb · director | A-Award | 2,500 | $9.20 |
Institutional positioning
13F filings over the trailing two quarters
New 8Increased 0Reduced 3Sold out 14
| Filer | Action | Shares | Filed |
|---|---|---|---|
| THOMPSON SIEGEL & WALMSLEY LLC | New Position | 232,120 | May 11, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 48,280 | May 15, 2026 |
| ARISTIDES CAPITAL LLC | New Position | 41,692 | May 14, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 28,011 | May 14, 2026 |
| EMPIRICAL FINANCIAL SERVICES, LLC D.B.A. EMPIRICAL WEALTH MANAGEMENT | New Position | 25,192 | May 4, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New Position | 13,720 | May 15, 2026 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | Unchanged | 12,500 | May 15, 2026 |
| CRESCENT GROVE ADVISORS, LLC | New Position | 10,723 | May 6, 2026 |
| SBI SECURITIES CO., LTD. | Unchanged | 3,128 | Apr 28, 2026 |
| MORGAN STANLEY | Reduced | 3,087 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 1,037 | May 8, 2026 |
| ADVISOR GROUP HOLDINGS, INC. | Unchanged | 500 | May 15, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | New Position | 109 | May 15, 2026 |
| JPMORGAN CHASE & CO | Reduced | 1 | May 13, 2026 |
| MORGAN STANLEY | Sold Out | 0 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 1, 2026